William R. Ringo, Director at FIVE PRIME THERAPEUTICS INC (FPRX), sold 500 shares at $46.17 ($23K) on 2017-02-01, disclosed to the SEC on 2017-02-01.
Scheduled sale ($23k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ASMB | SELL | 2018-06-01 | $42K | — | Filing → |
| ASMB | SELL | 2018-05-02 | $43K | — | Filing → |
| ASMB | SELL | 2018-04-02 | $49K | — | Filing → |